Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Case Report: Delayed Alemtuzumab-Induced Concurrent Neutropenia and Thrombocytopenia in Relapsing-Remitting Multiple Sclerosis.
Journal: Journal of pharmacy practice
Published: June 25, 2021
Characterization of hypereosinophilia in university health care systems.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: August 24, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls.
Journal: European journal of breast health
Published: February 24, 2020
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.
Journal: World journal of surgical oncology
Published: July 29, 2019
Learning, Life, and Lactation: Knowledge of Breastfeeding's Impact on Breast Cancer Risk Reduction and Its Influence on Breastfeeding Practices.
Journal: Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine
Published: October 26, 2018
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2018
Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Journal: Molecular cancer
Published: November 18, 2015
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Journal: Molecular cancer
Published: October 07, 2014
MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Journal: PloS one
Published: November 13, 2013
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
Journal: Breast cancer research and treatment
Published: January 25, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026